Bifidobacterium infantis
Product description
Highlights:
-16s rRNA genetic identified;
- IDA deposited;
- Safety study approved;
- ISO/HACCP/GMP/Halal certificated.
Product Name:
BI-G201 ;
Bifidobacterium infantis ;
B.infantis ;
Lactic acid bacteria;
Probiotics;
Introduction:
BI-G201 powder is composed of strains Bifidobacterium infantis BI-G201 and a special protective agent. It can be widely used as a food additive. B. infantis BI-G201 is isolated from the intestinal flora of breastfed, healthy infants. It is an anaerobic, gram-positive, bacterium. It is most abundant in infants since its numbers decline as we age. This decrease of probiotic bacteria, especially B. infantis, is closely related to the growth of pathogenic bacteria, diarrhea and other gastrointestinal diseases. Maintaining essential populations of B. infantis is critical to the suppression of harmful bacteria growth, the enhancement of infant immune function, and the reduction of infant diarrhea.
Applications:
BI-G201 :Yogurt, soy milk, milk powder, yogurt drinks, ice cream, butter, beverages,food supplements, and other products.
Ingredients:
Bifidobacterium infantis BI-G201 ;
Product Standard:
5.0x10^10 CFU/g
Recommended Dosage:
Daily dosage: ≥ 1x108 CFU/g
Storage Requirements:
Stored at temperatureunder -18°c, under sealed condition.
Read more
-16s rRNA genetic identified;
- IDA deposited;
- Safety study approved;
- ISO/HACCP/GMP/Halal certificated.
Product Name:
BI-G201 ;
Bifidobacterium infantis ;
B.infantis ;
Lactic acid bacteria;
Probiotics;
Introduction:
BI-G201 powder is composed of strains Bifidobacterium infantis BI-G201 and a special protective agent. It can be widely used as a food additive. B. infantis BI-G201 is isolated from the intestinal flora of breastfed, healthy infants. It is an anaerobic, gram-positive, bacterium. It is most abundant in infants since its numbers decline as we age. This decrease of probiotic bacteria, especially B. infantis, is closely related to the growth of pathogenic bacteria, diarrhea and other gastrointestinal diseases. Maintaining essential populations of B. infantis is critical to the suppression of harmful bacteria growth, the enhancement of infant immune function, and the reduction of infant diarrhea.
Applications:
BI-G201 :Yogurt, soy milk, milk powder, yogurt drinks, ice cream, butter, beverages,food supplements, and other products.
Ingredients:
Bifidobacterium infantis BI-G201 ;
Product Standard:
5.0x10^10 CFU/g
Recommended Dosage:
Daily dosage: ≥ 1x108 CFU/g
Storage Requirements:
Stored at temperatureunder -18°c, under sealed condition.
Specifications
| Categories | Nutrients; Probiotics |
|---|---|
| Sales markets | Western Europe; Eastern Europe; Asia; North America; Central/South America |
| Supplied from | China |
| Product Applications | Dietary Supplements; Food Supplements |
| Product Certifications | Health & Safety (GMP, HAACP and equivalents); Sustainable Seafood |
.png)
Bifidobacterium infantis
